| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |